BillionToOne, Inc.
NASDAQ:BLLNMedical - Diagnostics & Research
+$0.84 today
- Market cap
- $4.37B
- Beta
- 0.90
- P/E (TTM)
- 182.6
- EPS (TTM)
- $0.55
Volume 1.44M
Average 0.59M
BLLN Net Debt
Total debt minus cash and equivalents; a negative value means the company holds more cash than debt.
BillionToOne, Inc.NASDAQ: BLLN
Net Debt · Q2 FY2026 · quarter ended Jun 2026
Net debt remains negative
Q2 FY2026 net debt was -$404.71M, compared with -$82.23M a year earlier.
Context
- Net debt amounted to 55.5% of total assets at the end of Q2 FY2026, up 29.2 pp from a year earlier.
- Net debt increased in 0 of the last 2 fiscal years.
- FY2025 was the lowest annual figure in the 3 fiscal years shown.
What to watch
Whether net debt keeps falling in the next quarterly balance sheet after a -392.1% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Debt history
USD · from the balance sheet
- Latest · FY2025
- (387.08M) USD
- Year-over-year change
- -371.5%
| Period | Period end | Net Debt | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (387.08M) | -371.5% |
| FY2024 | 2024-12-31 | (82.1M) | -267.3% |
| FY2023 | 2023-12-31 | 49.08M | — |
Net Debt vs competitors
How BLLN compares with its peers on the latest reported figures
- BLLN's Jun 2026 net debt of -$404.71M is the 8th highest of the 9 companies compared; the peer median is $61.38M.
- Its year-over-year change of -392.1% is the lowest of 9, against a peer median of +25.1%.
- Net debt amounts to 55.5% of total assets for BLLN, versus a peer median of 19.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $664.59M | -11.0% | +2.8% | 35.2% | |
| Jun 2026 | $302.83M | +17.8% | -3.5% | 22.4% | |
WGSGeneDx Holdings Corp. | Jun 2026 | $107.09M | +166.0% | — | 22.2% |
| Mar 2026 | $87.1M | +32.4% | -11.9% | 12.9% | |
| Jun 2026 | $35.66M | +154.6% | — | 1.3% | |
| Mar 2026 | -$13.23M | +77.8% | — | 1.1% | |
| Jun 2026 | -$259.41M | -53.6% | — | 17.5% | |
BLLNBillionToOne, Inc. | Jun 2026 | -$404.71M | -392.1% | — | 55.5% |
| Jun 2026 | -$853.01M | -6.1% | — | 32.1% | |
| Peer median (excluding BLLN) | $61.38M | +25.1% | -3.5% | 19.8% | |
Competitors are the stored peer set for BLLN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BillionToOne, Inc.
NASDAQ:BLLN
Intrinsic Alpha fair value
Locked
Current Price
$91.54
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.